Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$193.94
+1.6%		$201.51
$101.00
▼
$247.49
$12.18B0.83581,959 shs599,316 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.95
-0.1%		$23.73
$20.02
▼
$27.64
$12.33B0.76592,280 shs363,861 shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$12.79
-2.1%		$11.81
$4.77
▼
$13.56
$4.99B1.224.13 million shs5.25 million shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$69.97
+1.6%		$56.42
$40.77
▼
$104.32
$12.42B3.728.14 million shs7.56 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
+1.49%+5.91%+9.90%-6.60%+49.16%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
-0.13%+2.78%-2.53%-2.74%-9.52%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-2.07%+1.35%+1.91%+42.43%+144.55%
Tempus AI, Inc. stock logo
TEM
Tempus AI
+1.63%+14.18%+35.50%+37.63%-19.61%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DaVita Inc. stock logo
DVA
DaVita
$193.94
+1.6%		$201.51
$101.00
▼
$247.49
$12.18B0.83581,959 shs599,316 shs
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.95
-0.1%		$23.73
$20.02
▼
$27.64
$12.33B0.76592,280 shs363,861 shs
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$12.79
-2.1%		$11.81
$4.77
▼
$13.56
$4.99B1.224.13 million shs5.25 million shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$69.97
+1.6%		$56.42
$40.77
▼
$104.32
$12.42B3.728.14 million shs7.56 million shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DaVita Inc. stock logo
DVA
DaVita
+1.49%+5.91%+9.90%-6.60%+49.16%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
-0.13%+2.78%-2.53%-2.74%-9.52%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
-2.07%+1.35%+1.91%+42.43%+144.55%
Tempus AI, Inc. stock logo
TEM
Tempus AI
+1.63%+14.18%+35.50%+37.63%-19.61%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DaVita Inc. stock logo
DVA
DaVita
2.57
Moderate Buy$233.4320.36% Upside
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.55
Reduce$23.572.71% Upside
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2.73
Moderate Buy$12.880.66% Upside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.43
Hold$69.33-0.91% Downside

Current Analyst Ratings Breakdown

Latest LFST, TEM, FMS, and DVA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
9/11/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$56.00 ➝ $66.00
9/10/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$13.00 ➝ $15.00
9/9/2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$13.00 ➝ $15.00
9/9/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$70.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
9/8/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$67.00
9/2/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$80.00
9/2/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$80.00
9/1/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutral ➝ Overweight$56.00 ➝ $76.00
(Data available from 9/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DaVita Inc. stock logo
DVA
DaVita
$13.64B0.91$22.06 per share8.79($5.29) per share-36.66
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$22.20B0.56$5.57 per share4.12$28.93 per share0.79
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$1.42B3.43$0.16 per share77.64$3.91 per share3.27
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.27B9.93N/AN/A$2.76 per share25.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DaVita Inc. stock logo
DVA
DaVita
$746.80M$12.2215.8711.240.496.05%-217.63%5.07%10/28/2026 (Estimated)
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$1.11B$1.9311.899.764.264.83%9.28%4.16%11/3/2026 (Estimated)
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$9.66M$0.1398.3955.61N/A3.19%3.39%2.33%11/5/2026 (Estimated)
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.44N/AN/AN/A-17.77%-50.28%-10.33%11/3/2026 (Estimated)

Latest LFST, TEM, FMS, and DVA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
$0.0328$0.06+$0.0273$0.06$414.58 million$435.35 million
8/4/2026Q2 2026
DaVita Inc. stock logo
DVA
DaVita
$3.88$4.02+$0.14$4.02$3.50 billion$3.55 billion
8/3/2026Q2 2026
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.6160$0.66+$0.0440$0.46$5.48 billion$5.55 billion
7/30/2026Q2 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.1428-$0.04+$0.1028$0.03$379.69 million$382.49 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DaVita Inc. stock logo
DVA
DaVita
N/AN/AN/AN/AN/A
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
$0.612.66%+2.66%31.61%N/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
N/AN/AN/AN/AN/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DaVita Inc. stock logo
DVA
DaVita
N/A
1.47
1.41
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
0.43
1.07
0.75
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
0.18
1.38
1.38
Tempus AI, Inc. stock logo
TEM
Tempus AI
3.06
3.30
3.16

Institutional Ownership

CompanyInstitutional Ownership
DaVita Inc. stock logo
DVA
DaVita
90.12%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
8.37%
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
85.50%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
DaVita Inc. stock logo
DVA
DaVita
1.90%
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
N/A
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
3.50%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
DaVita Inc. stock logo
DVA
DaVita
78,00063.80 million62.59 millionOptionable
Fresenius Medical Care AG & Co. KGaA stock logo
FMS
Fresenius Medical Care AG & Co. KGaA
1,488537.13 millionN/AOptionable
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
10,961382.15 million368.78 millionOptionable
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800180.43 million136.66 millionN/A

Recent News About These Companies

Tempus AI, Inc. (NASDAQ:TEM) Receives Average Rating of "Hold" from Brokerages
 |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31028081
Tempus AI, Inc. (NASDAQ:TEM) Given Consensus Rating of "Hold" by Analysts
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-tempus-ai-inc-nasdaq-tem-given-consensus-rating-of-hold-by-analysts-2026-09-17/
Tempus AI (TEM) Stock Surges 11% on Piper Sandler Upgrade and Federal Grant News
September 16 at 12:09 PM  |  blockonomi.comhttps://blockonomi.com/tempus-ai-tem-stock-surges-11-on-piper-sandler-upgrade-and-federal-grant-news/
Tempus AI (TEM) Stock Jumps 11% After Piper Sandler Upgrade and New Catalysts
September 16 at 12:09 PM  |  coincentral.comC
Top Artificial Intelligence Stocks Worth Watching - September 16th
September 16 at 12:01 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/list-top-artificial-intelligence-stocks-worth-watching-september-16th-2026-09-16/
Tempus AI leads the session with a 10.5% gain as losers bite harder
September 15 at 7:26 PM  |  247wallst.comhttps://247wallst.com/cards/tempus-ai-closed-the-session-up-10-5-the-only-double-digit-tem-session-movers-01m2kb4q88fc5zyhpzzyqyksvw
Tempus AI, Inc. (TEM) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
September 15 at 2:26 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4946476-tempus-ai-inc-tem-presents-at-morgan-stanley-24th-annual-global-healthcare-conference
Tempus AI (NASDAQ:TEM) Shares Up 3.9% - Here's Why
September 15 at 12:59 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-tempus-ai-nasdaq-tem-shares-up-39-heres-why-2026-09-15/
ARPA-H funds $62.7M in AI agents for heart failure care
September 15 at 9:26 AM  |  yahoo.comhttps://www.yahoo.com/news/science/articles/arpa-h-funds-62-7m-123100797.html
Watch CNBC's full interview with Tempus AI CEO Eric Lefkofsky
September 14 at 2:39 PM  |  cnbc.comhttps://www.cnbc.com/video/2026/09/14/watch-cnbcs-full-interview-with-tempus-ai-ceo-eric-lefkofsky.html
Tempus AI CEO Eric Lefkofsky: Healthcare will likely be the biggest beneficiary of AI
September 14 at 2:39 PM  |  msn.comhttps://www.msn.com/en-us/news/other/tempus-ai-ceo-eric-lefkofsky-healthcare-will-likely-be-the-biggest-beneficiary-of-ai/vi-AA2cd5vw
HC Wainwright Raises Tempus AI (NASDAQ:TEM) Price Target to $66.00
September 13, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31019841
Tempus AI, Inc. Launches Effort To Build The Largest Multimodal Whole-Genome Dataset To Advance AI-Driven Healthcare Innovation
September 12, 2026  |  marketscreener.comM
Tempus AI to Build Dataset of 100,000 Whole Genomes for AI Research
September 11, 2026  |  marketwatch.comhttps://www.marketwatch.com/story/tempus-ai-to-build-dataset-of-100-000-whole-genomes-for-ai-research-142959c2
ARPA-H to award $62.7M for AI in cardiovascular care
September 11, 2026  |  medtechdive.comM
Tempus AI Building Multimodal Whole-Genome Dataset for AI Research
September 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/technology/ai/articles/tempus-ai-building-multimodal-whole-130228459.html
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
September 11, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260911945729/en/Tempus-Launches-Effort-to-Build-the-Largest-Multimodal-Whole-Genome-Dataset-to-Advance-AI-Driven-Healthcare-Innovation/
Nvidia, Snowflake, Chubb And A Health Care Stock On CNBC's ‘Final Trades'
September 11, 2026  |  benzinga.comhttps://www.benzinga.com/trading-ideas/long-ideas/26/09/61736779/nvidia-snowflake-chubb-and-a-health-care-stock-on-cnbcs-final-trades?utm_source=snapi
Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, HC Wainwright Analyst Says
September 11, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-tempus-ai-nasdaq-tem-stock-price-expected-to-rise-hc-wainwright-analyst-says-2026-09-11/
Final trades: Snowflake, Tempus AI, Chubb and Nvidia
September 11, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/final-trades-snowflake-tempus-ai-chubb-and-nvidia/vi-AA2bXSl6
UBS Group Initiates Coverage on Tempus AI (NASDAQ:TEM)
September 11, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31016015

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Illustration of an upward-trending stock chart line overlaid on a city skyline of office towers at sunset.
Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
By Nathan Reiff | August 30, 2026
MongoDB logo displayed in a server room aisle lined with illuminated data center racks.
MongoDB Is Surging—And the Next Catalyst Is Almost Here
By Thomas Hughes | August 24, 2026
Laptop displaying a candlestick stock price chart on a desk with autumn leaves and the word September overlaid.
5 Stocks to Buy in September Before Wall Street Catches On
By Thomas Hughes | August 26, 2026
Foldable Apple smartphone displayed on a table with a lit Apple logo and city skyline in the background.
Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
By Sam Quirke | August 30, 2026
Close-up of a carbon fiber surface bearing the AV logo and a camera sensor.
AeroVironment’s $465 Million Army Laser Win Expands Its Counter-Drone Opportunity
By Ryan Hasson | September 3, 2026
DaVita stock logo

DaVita NYSE:DVA

$193.94 +3.04 (+1.59%)
Closing price 09/16/2026 03:59 PM Eastern
Extended Trading
$195.88 +1.95 (+1.00%)
As of 06:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Fresenius Medical Care AG & Co. KGaA stock logo

Fresenius Medical Care AG & Co. KGaA NYSE:FMS

$22.94 -0.02 (-0.07%)
Closing price 09/16/2026 03:59 PM Eastern
Extended Trading
$22.83 -0.12 (-0.50%)
As of 06:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

LifeStance Health Group stock logo

LifeStance Health Group NASDAQ:LFST

$12.79 -0.27 (-2.07%)
Closing price 09/16/2026 04:00 PM Eastern
Extended Trading
$12.68 -0.11 (-0.85%)
As of 04:25 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$69.97 +1.12 (+1.63%)
Closing price 09/16/2026 04:00 PM Eastern
Extended Trading
$71.26 +1.29 (+1.84%)
As of 06:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas